Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer
RomaniaA study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata
RomaniaA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
RomaniaA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
RomaniaA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
RomaniaStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
RomaniaA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
RomaniaStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
RomaniaA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
RomaniaA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
RomaniaLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
RomaniaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
RomaniaTell us about your condition – we search every trial in Europe and connect you with the right site.
